SPY305.94+0.39 0.13%
DIA256.42+1.15 0.45%
IXIC9,502.02-50.03 -0.52%

Assertio Therapeutics Q1 Adj. EPS $0.100 Beats $(0.080) Estimate, Sales $20.917M Beat $11.300M Estimate

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.100 per share which beat the analyst consensus estimate of $(0.080) by 225 percent. This is a 56.52 percent decrease over earnings of $0.230 per share

Benzinga · 05/11/2020 12:20

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.100 per share which beat the analyst consensus estimate of $(0.080) by 225 percent. This is a 56.52 percent decrease over earnings of $0.230 per share from the same period last year. The company reported quarterly sales of $20.917 million which beat the analyst consensus estimate of $11.300 million by 85.11 percent. This is a 63.89 percent decrease over sales of $57.929 million the same period last year.